Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Stora Enso appoints Annica Bresky as President and Chief Executive Officer

STORA ENSO OYJ INSIDER INFORMATION 25 September 2019 at 8.00 EESTStora Enso’s Board of Directors has appointed Annica Bresky, 44, as the new President and CEO of the company as of 1 December 2019. Until then, Stora Enso’s current CEO Karl-Henrik Sundström continues in his position. Bresky is currently Head of Stora Enso’s Consumer Board division.“We are very happy to welcome Annica Bresky into her new position. Annica brings extensive experience of our industry and has a solid business background. We consider her the most suitable person to continue developing Stora Enso’s strategy and

Improved mapping of Swedish genes

People – or more specifically just Swedes – are more like chimpanzees than previously known. This is indicated in a genetic mapping of one thousand Swedish individuals, where new DNA sequences that should be included in the reference genome have been identified. The study is published in the scientific journal Molecular Biology and Evolution.In so-called whole genome sequencing, surveys are made of the total genome of an individual. It is still relatively rare in healthcare today, but it occurs at an increasing rate, for example in order to make an accurate diagnosis in the case of a rare

Great interest in DrugLog® at Drug Diversion conference

The IHFDA is holding its annual conference in Orlando September 23-25. It is aimed at decision makers and leading pharmacists in the health care sector who work with Drug Diversion prevention programs. The need to control returned narcotics from the OR is increasing and both delegates and representatives from major multinational companies have shown great interest in DrugLog®.The International Health Facility Diversion Association (IHFDA) holds its annual conference in Orlando September 23-25 and attracts approximately 200 delegates from US hospitals. It is aimed at decision makers and

Update on funding

Global Scanning enters into a SEK 235,000,000 facility agreement with Scandinavian Credit FundOn 28 August 2019, it was announced that Global Scanning A/S ("Global Scanning" or the "Group") has received credit committee approval from a third-party lender for a bilateral loan, to be used to refinance the Group’s outstanding SEK 200,000,000 bonds and for general corporate purposes. Global Scanning now announces that a SEK 235,000,000 facility agreement has been entered into.    On 24 September 2019, Global Scanning entered into a facility agreement with Scandinavian Credit Fund relating

Major League Baseball Players Alumni Association Brings Swing with the Legends Golf Classic to Baltimore, MD

Event to feature 1983 Baltimore Orioles World Series champion teammates and other former MLB playersColorado Springs, Colo. – The Major League Baseball Players Alumni Association will host a Swing with the Legends celebrity golf tournament featuring former Orioles, All-Stars, World Series champions and other baseball alumni. The golf tournament will take place on Friday, September 27th, 2019 with proceeds benefitting the Cal Ripken Sr. Foundation  and the MLBPAA. Alumni players attending* the event include 1983 Baltimore Orioles World Series champion

Industry-leading UPM Raflatac RAFNXT+ sustainable paper label materials now available in the Americas

(UPM Raflatac, Las Vegas, NV, USA, September 24, 2019 at 21:00 EET) – The next generation for sustainable packaging is now available in the Americas with the introduction of the UPM Raflatac RAFNXT+ paper label range. Unveiled at Pack Expo Las Vegas 2019, these materials feature UPM Raflatac’s Forest Positive lifecycle approach, benefitting nature and the environment as a whole. New RAFNXT+ paper laminates are ideal for a wide range of applications, including food, home and personal care, retail, logistics, and home and office. Not only does the Forest Positive approach go beyond

Windevo AB initiates written procedure

Windevo AB initiates written procedures regarding its up to SEK 50,000,000 Subordinated Second Lien Secured Callable PIK Interest Bonds 2018/2023a restructuring of its senior secured bonds 2015/2019 and its Maximum SEK 62,000,000 Senior Secured Callable Fixed Rate Bonds 2018/2021Windevo AB (the “Company” or the “Issuer”) summons meetings among the bondholders by way of a procedure in writing (the “Written Procedures”) for its outstanding bonds ISIN: SE0011337120 up to SEK 50,000,000 Subordinated Second Lien Secured Callable PIK Interest Bonds 2018/2023 and ISIN: SE0011337146 and

Enersize Oyj carries out a partially guaranteed rights issue of approximately 47 MSEK and publishes prospectus

The Board of Directors in Enersize Oyj (”Enersize” or the ”Company”) has today, following authorization given by the Extraordinary General Meeting, resolved on an issue of shares and warrants with preferential rights for the Company's existing shareholders (the "Rights Issue") announced 3 September 2019. The offering consists of a maximum of 72,403,016 new shares and a maximum of 36,201,508 warrants.Summary · The Rights Issue may, upon full subscription, provide Enersize with up to approximately 47 MSEK, before transaction costs related to the issue. Upon full subscription and full

Communication from Enersize Oyj's Extraordinary General Meeting

Today, September 24, 2019, an Extraordinary General Meeting was held in Enersize Oyj. Below is a summary of the decisions that were made. All decisions were taken unanimously.Resolution at Enersize Oyj's Extraordinary General Meeting Enersize Oyj's Extraordinary General Meeting was held on 24.9.2019 in Helsinki. A total of 3 shareholders, 12,141,675 shares and votes were represented at the Extraordinary General Meeting. The following issues were discussed at the General Meeting: Election of a new board member The General Meeting decided to elect a fifth Board member. Anders

Aripiprazol EQL Pharma approved

The pharmaceutical Aripiprazole EQL Pharma, oral solution 1mg / ml, has been approved by the Swedish Medicines Agency for sale.Aripiprazole EQL Pharma is a prescription drug used to treat schizophrenia in adults and adolescents from the age of 15 years. Aripiprazole EQL Pharma is also used to treat moderate to severe manic episodes in bipolar disorder. Aripiprazole EQL Pharma contains aripiprazole, a substance that has been registered as an oral solution in Sweden since 2005. The market for aripiprazole oral solution is limited to approximately SEK 2 million in total annual sales in

EAB GROUP PLC: ACQUISITION OF OWN SHARES 24.09.2019

EAB GROUP PLC  NOTIFICATION 24.09.2019 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 24.09.2019 Date 24.09.2019Exchange transaction BuyShare class EABAmount 110 Average price/share 2.8200 EUR  Highest price/share 2.8200 EUR Lowest price/share 2.8200 EUR Total price  310.20 EUR  The shares held by EAB Group Plc on 24.09.2019: EAB 1,135 On behalf of EAB Group Plc Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Mikko Virtanen For more information, please

United Bankers Corporation: Acquisition of Own Shares 24.09.2019

United Bankers Corporation NOTIFICATION 24.09.2019 at 18:30 UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 24.09.2019 Date 24.09.2019Exchange transaction BuyShare class UNIAVAmount 190Average price/share 8.0000 EURHighest price/share 8.0000 EURLowest price/share 8.0000 EURTotal price 1,520.00 EUR The shares held by United Bankers Corporation on 24.09.2019: UNIAV 25,552 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ) Antti Salakka

Atea acquires DatabaseForum AS

Atea AS (“Atea Norway”) has entered into an agreement to acquire DatabaseForum AS (“DatabaseForum”), a provider of business intelligence and data analytics in Norway. DatabaseForum is located in Stavanger, with a team of 16 highly skilled employees.“As organizations transform their operations through the use of data, Atea is expanding its competence within data analytics,” commented Michael Jacobs, Managing Director of Atea Norway. “With the acquisition of DatabaseForum, Atea has a team of over 100 consultants who can support our customers with the use of data analytics solutions to gain

IRRAS Announces Participation at the 19th European Congress of Neurosurgery

Stockholm, September 24, 2019 – IRRAS, a medical technology company focused on commercializing innovative solutions for neurocritical care, announced today it will be exhibiting at EANS2019, the 19thEuropean Congress of Neurosurgery, hosted by the European Association of Neurological Societies. EANS2019 is being held at the Convention Center Dublin, in Dublin, Ireland, on September 24-28, 2019. Conference attendees are invited to visit IRRAS in booth #29 to learn more about IRRAflow®, the world’s first irrigating ventricular drainage system. IRRAflow’s unique mechanism of action

Cities: Skylines - Campus Expansion Now Available for Consoles

Buildings for Higher-Education Create Urbanization; Content Creator Pack: University City and Radio Station Pack 3 Also AvailableSTOCKHOLM - SEPTEMBER 24, 2019 - Paradox Interactive today announced that school is back in session with the release of Cities: Skylines - Campus on Xbox One and PlayStation®4. Available now for $12.99 MSRP, Campus adds university area types, reputation building, Academic Works, varsity sports arenas, unique faculties, policies, achievements, and maps. Watch the trailer: https://youtu.be/XAZwO4Mtiac "Campus allows players to further diversify their cities by

Scandion Oncology CEO Newsletter autumn 2019

Dear Scandion Oncology shareholder, Scandion Oncology is heading towards an exciting future where we will, hopefully, deliver a new cancer treatment to the market. One that can help overcome chemotherapy resistance - an accomplishment that truly would mark a new dawn for modern cancer treatment.Mastering the global challenge of eradicating drug resistance  Two months have now passed since we finalized our successful rights issue. The right issue provided Scandion Oncology with the financial means to conduct the two planned clinical phase II trials in cancer patients with metastatic

#19-1061 Delisting of certain derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#19-1060 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Getinge presents intensive care portfolio at European Society of Intensive Care Medicine Congress 2019

Getinge announces its commitment to the European Society of Intensive Care Medicine, supporting the education and training of clinicians in the intensive care environment. Getinge partners with clinicians to ensure that every treatment for post-operative patients, those patients with acute medical conditions and for neonates, goes according to plan with improved clinical outcomes and reduced length of stay. “Our experienced intensive care specialists collaborate with clinicians to find the right innovative advanced life support solutions and patient monitoring technologies’ shared Markus

Correction: Improved treatment technology in the fight against prostate cancer is used directly in an ongoing clinical trial

Correction concerning inaccurate reference under the EU Market Abuse Regulation (MAR). The pressrelease without reference is found below. Improved treatment technology in the fight against prostate cancer is used directly in an ongoing clinical trial The collaboration between SpectraCure and the German company MedCom GmbH has reached a stage where the technology will be used in SpectraCure's ongoing clinical study. The technology leads to increased precision, accuracy and safety in the treatment of recurrent prostate cancer.  SpectraCure runs an EU-funded development project,

Nomination Committee ahead of Indutrade’s AB’s 2020 Annual General Meeting

Indutrade’s Annual General Meeting on 6 May 2013 adopted an instruction for the Nomination Committee of Indutrade AB (publ) that applies until further notice. According to this instruction, the Nomination Committee shall be composed of representatives of four of the largest shareholders in terms of votes (owner-grouped), plus the Chairman of the Board. The member representing the largest shareholder shall serve as committee chair. In the event a member resigns from the Nomination Committee prior to the completion of its work, if the Nomination Committee finds it suitable a replacement shall

Year End Report and Annual Report - 30th June 2019

The Year In Brief   Year ended 30th June 2019    · Sales for the year SEK 22.5m (FY2018: SEK 35.3m) Decline of 36%.   · EBITDA deficit of SEK 24m (FY2018: Surplus SEK 6.3m).   · Cash balances SEK 15m (FY2018: SEK 47.3).   · Salam Technology contract in Qatar finished in July 2018 (Value in FY2018 in the region of SEK 14M).   · Salam Technology receivable remains outstanding and continues to be actively pursued.   · Steady increase in underlying sales.   · Appointment of new Chairman (July 2019).   · Appointment of new CEO (September 2019).   · Facility

Cimco Marine AB (publ) enters into letter of intent with African governmental supplier

Cimco Marine AB (publ) (the “Company”) has today entered into a letter of intent with an African governmental supplier to, via its sub-Saharan distributor Southern Power Products (Pty) Ltd, supply an African government with its OXE150s/200s to power their new Rigid Inflatable Boats (RIBs). The expected total revenue from this project is approx. EUR 5 million including accessories, service kits and spare parts. This project is phase one of a multi-phase program with this government. Delivery of the OXE units is conditional upon the OXE receiving the end customer’s approval after sea

There are no items matching the current filter
There are no more items matching the current filter
Back to top